Celgene’s Revlimid In Multiple Myeloma Reviewed At ASCO For Risk Of Thrombosis
This article was originally published in The Pink Sheet Daily
Executive Summary
Study finds that concurrent use of erythropoietin agents with Revlimid and dexamethasone should be minimized.